Carsten Brunn's Insider Trades & SAST Disclosures
Carsten Brunn's most recent trade in Cartesian Therapeutics Inc was a trade of 8,708 Common Stock done at an average price of $16.8 . Disclosure was reported to the exchange on Jan. 3, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Carsten Brunn.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.83 per share. | 03 Jan 2025 | 8,708 | 204,096 (0%) | 0% | 16.8 | 146,575 | Common Stock |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 16.72 per share. | 03 Jan 2025 | 8,563 | 212,804 (0%) | 0% | 16.7 | 143,190 | Common Stock |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 169,100 | 169,100 | - | - | Employee Stock Option (right to buy) | |
| Cartesian Therapeutics Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 57,500 | 221,367 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 5,971,000 | 5,971,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 4,654,100 | 4,916,056 (5%) | 5% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 27,549 | 799,534 (0%) | 0% | 1.1 | 31,232 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 04 Jan 2023 | 13,396 | 786,090 (0%) | 0% | 1.1 | 15,128 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 04 Jan 2023 | 77 | 786,013 (0%) | 0% | 1.1 | 86 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.15 per share. | 04 Jan 2023 | 48 | 799,486 (0%) | 0% | 1.1 | 55 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 1,275,000 | 1,275,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 282,800 | 827,083 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.33 per share. | 05 Dec 2022 | 4,522 | 544,283 (0%) | 0% | 1.3 | 6,014 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 10,938 | 0 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 10,938 | 548,805 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,937 | 545,327 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 10,937 | 10,938 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.85 per share. | 01 Sep 2022 | 4,768 | 540,559 (0%) | 0% | 1.8 | 8,810 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 10,938 | 21,875 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 10,938 | 534,390 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,937 | 32,813 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2022 | 10,937 | 528,895 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 1.81 per share. | 01 Mar 2022 | 5,443 | 523,452 (0%) | 0% | 1.8 | 9,863 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.09 per share. | 05 Jan 2022 | 13,597 | 517,958 (0%) | 0% | 3.1 | 41,959 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,056,100 | 1,056,100 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 226,300 | 531,555 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.99 per share. | 10 Dec 2021 | 17,196 | 305,255 (0%) | 0% | 3.0 | 51,363 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2021 | 37,500 | 322,451 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 10,938 | 289,697 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 10,938 | 43,750 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.96 per share. | 01 Dec 2021 | 4,746 | 284,951 (0%) | 0% | 3.0 | 14,065 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Oct 2021 | 15,313 | 278,759 (0%) | 0% | 4.4 | 67,224 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 37,500 | 294,072 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 163,000 | 163,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Sep 2021 | 27,200 | 256,572 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 10,937 | 54,688 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 10,937 | 233,895 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.51 per share. | 01 Sep 2021 | 4,523 | 229,372 (0%) | 0% | 4.5 | 20,399 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 10,938 | 227,764 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 10,938 | 65,625 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 01 Jun 2021 | 4,806 | 222,958 (0%) | 0% | 4.4 | 21,041 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 10,937 | 76,563 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 10,937 | 222,287 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 4.26 per share. | 01 Mar 2021 | 5,461 | 216,826 (0%) | 0% | 4.3 | 23,257 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 670,000 | 670,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 110,000 | 211,350 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 10,938 | 87,500 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2020 | 10,938 | 104,673 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.35 per share. | 01 Dec 2020 | 3,323 | 101,350 (0%) | 0% | 3.4 | 11,134 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 10,937 | 97,099 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2020 | 10,937 | 98,438 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 2.39 per share. | 01 Sep 2020 | 3,364 | 93,735 (0%) | 0% | 2.4 | 8,035 | Common Stock |
| Selecta Biosciences Inc | Carsten Brunn | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 75,000 | 75,000 | - | - | Employee Stock Option (right to buy) | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 10,938 | 109,375 | - | - | Restricted Stock Units | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2020 | 10,938 | 89,415 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Carsten Brunn | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 3.86 per share. | 01 Jun 2020 | 3,253 | 86,162 (0%) | 0% | 3.9 | 12,557 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges